Medical Countermeasures | Global Biodefense

Menu

Latest stories

Crimean-Congo Hemorrhagic Fever

Crimean Congo Countermeasures: Researchers Investigate CCHFV-RDRp

DARPA Biological Technologies

DARPA Seeks First-in-Human Therapeutic Interfering Particles Targeting Respiratory Viruses

More on pathogens and preparedness

FDA Authorizes Marketing of First Diagnostic Test for Zika Virus Antibodies

by Global Biodefense May 23, 2019, 8:15 am
Daiichi Sankyo Apologizes for Not Meeting Vaccine Production Milestone for Pandemic Preparedness

by Global Biodefense May 22, 2019, 9:03 am
Phage Therapy to Prevent Cholera Infections – and Possibly Those Caused by Other Deadly Bacteria
Popular

Army Planning to Begin User Acceptance Testing of Malaria Drug Tafenoquine

by Global Biodefense April 21, 2019, 10:13 am
Radiation Nuclear Countermeasures Centralized Dosimetry Harmonization Effort

by Global Biodefense April 21, 2019, 9:22 am
Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons

by Global Biodefense April 15, 2019, 8:16 am
Counterfeit Medications: What We Know and What Needs to be Done
Why the Scientific Debate Over a UW Bird Flu Study Isn’t Going Away

by Will Cushman, WisContext March 16, 2019, 6:58 pm
CRADA Opportunity: Developing Protein Nanoparticles for the Display of Viral Epitopes

by Global Biodefense March 13, 2019, 11:23 am
Why Ebola Vaccine on Trial in DRC is Raising Hopes

by Shirin Ashraf and Arthur Wickenhagen, University of Glasgow February 10, 2019, 11:21 pm
US Invests Additional 44 Million in Smallpox Vaccine Manufacturing
New Vaccine Manufacturing Innovation Centre Bolsters UK Pandemic Preparedness

by Global Biodefense January 22, 2019, 3:00 am

Congratulations. You've reached the end of the internet.

Back to Top

Close

close